These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38412237)

  • 1. Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors.
    Sun C; He Y; Wang G; Zhang G; Zhang Y; Shen H; Hu L; Sun Y; Jiang B; Wang X; Yuan K; Min W; Wang L; Sun H; Xiao Y; Yang P
    J Med Chem; 2024 Mar; 67(5):3590-3605. PubMed ID: 38412237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Basis of VSIG3: The Ligand for VISTA.
    Xie X; Chen C; Chen W; Jiang J; Wang L; Li T; Sun H; Liu J
    Front Immunol; 2021; 12():625808. PubMed ID: 33841409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small molecule inhibitor of VSIG-8 prevents its binding to VISTA.
    Chen W; Qie C; Hu X; Wang L; Jiang J; Liu W; Liu J
    Invest New Drugs; 2022 Aug; 40(4):690-699. PubMed ID: 35404016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation.
    Mehta N; Maddineni S; Mathews II; Andres Parra Sperberg R; Huang PS; Cochran JR
    Cell Rep; 2019 Sep; 28(10):2509-2516.e5. PubMed ID: 31484064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VISTA is an immune checkpoint molecule for human T cells.
    Lines JL; Pantazi E; Mak J; Sempere LF; Wang L; O'Connell S; Ceeraz S; Suriawinata AA; Yan S; Ernstoff MS; Noelle R
    Cancer Res; 2014 Apr; 74(7):1924-32. PubMed ID: 24691993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct immune stimulatory effects of anti-human VISTA antibodies are determined by Fc-receptor interaction.
    Mostböck S; Wu HH; Fenn T; Riegler B; Strahlhofer S; Huang Y; Hansen G; Kroe-Barrett R; Tirapu I; Vogt AB
    Front Immunol; 2022; 13():862757. PubMed ID: 35967294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA.
    Li TT; Jiang JW; Qie CX; Xuan CX; Hu XL; Liu WM; Chen WT; Liu J
    BMC Immunol; 2021 Aug; 22(1):55. PubMed ID: 34380434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Optimization of Small-Molecule Ligands for V-Domain Ig Suppressor of T-Cell Activation (VISTA).
    Gabr MT; Gambhir SS
    J Am Chem Soc; 2020 Sep; 142(38):16194-16198. PubMed ID: 32894020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Benzimidazoles as Potent Small-Molecule Inhibitors and Degraders of V-Domain Ig Suppressor of T-Cell Activation (VISTA).
    Wang T; Wang K; Zhang Y; Zhang K; Cai S; Jiang S; Xiao Y; Zhang X
    J Med Chem; 2023 Sep; 66(17):11881-11892. PubMed ID: 37594853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M351-0056 is a novel low MW compound modulating the actions of the immune-checkpoint protein VISTA.
    Hu X; Qie C; Jiang J; Xie X; Chen W; Liu W; Liu J
    Br J Pharmacol; 2021 Mar; 178(6):1445-1458. PubMed ID: 33450048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer.
    Xie X; Zhang J; Shi Z; Liu W; Hu X; Qie C; Chen W; Wang Y; Wang L; Jiang J; Liu J
    Front Immunol; 2020; 11():563044. PubMed ID: 33250890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VISTA Regulates the Development of Protective Antitumor Immunity.
    Le Mercier I; Chen W; Lines JL; Day M; Li J; Sergent P; Noelle RJ; Wang L
    Cancer Res; 2014 Apr; 74(7):1933-44. PubMed ID: 24691994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy.
    Yuan L; Tatineni J; Mahoney KM; Freeman GJ
    Trends Immunol; 2021 Mar; 42(3):209-227. PubMed ID: 33495077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VISTA immune regulatory effects in bypassing cancer immunotherapy: Updated.
    Mortezaee K; Majidpoor J; Najafi S
    Life Sci; 2022 Dec; 310():121083. PubMed ID: 36265568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationally targeted anti-VISTA antibody that blockades the C-C' loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner.
    Thakkar D; Paliwal S; Dharmadhikari B; Guan S; Liu L; Kar S; Tulsian NK; Gruber JJ; DiMascio L; Paszkiewicz KH; Ingram PJ; D Boyd-Kirkup J
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35131861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression.
    Xu W; Dong J; Zheng Y; Zhou J; Yuan Y; Ta HM; Miller HE; Olson M; Rajasekaran K; Ernstoff MS; Wang D; Malarkannan S; Wang L
    Cancer Immunol Res; 2019 Sep; 7(9):1497-1510. PubMed ID: 31340983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Benzo[
    Wang K; Cai S; Cheng Y; Qi Z; Ni X; Zhang K; Xiao Y; Zhang X; Wang T
    J Med Chem; 2024 Oct; 67(20):18526-18548. PubMed ID: 39389791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory functions of VISTA.
    Nowak EC; Lines JL; Varn FS; Deng J; Sarde A; Mabaera R; Kuta A; Le Mercier I; Cheng C; Noelle RJ
    Immunol Rev; 2017 Mar; 276(1):66-79. PubMed ID: 28258694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses.
    Wang L; Rubinstein R; Lines JL; Wasiuk A; Ahonen C; Guo Y; Lu LF; Gondek D; Wang Y; Fava RA; Fiser A; Almo S; Noelle RJ
    J Exp Med; 2011 Mar; 208(3):577-92. PubMed ID: 21383057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis.
    Ghouzlani A; Lakhdar A; Rafii S; Karkouri M; Badou A
    Sci Rep; 2021 Nov; 11(1):21504. PubMed ID: 34728682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.